首页> 外文OA文献 >Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics

【2h】

Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics

机译：对新诊断为急性髓样白血病且细胞遗传学风险中等或中等风险的老年患者进行的地西他滨与治疗选择支持治疗或阿糖胞苷的随机，多国，3期试验的多变量和亚组分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jiří Mayer; Christopher Arthur; Jacques Delaunay; Grzegorz Mazur; Xavier G Thomas; Agnieszka Wierzbowska; Farhad Ravandi; Erhan Berrak; Mark Jones; Yuhan Li; Hagop M Kantarjian;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics [J] . Ji?í Mayer, Christopher Arthur, Jacques Delaunay, BMC Cancer . 2014,第1期

机译：地西他滨与新诊断为急性髓样白血病且细胞遗传学风险中等或中等风险的老年患者的地西他滨与治疗选择支持治疗或阿糖胞苷的随机，多国，3期临床试验的多变量和亚组分析
2. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia [J] . KantarjianH.M., ThomasX.G., DmoszynskaA., Journal of Clinical Oncology . 2012,第21期

机译：地西他滨与患者选择的多中心，随机，开放标签III期试验，在医生的建议下，支持治疗或小剂量阿糖胞苷治疗新诊断为急性髓性白血病的老年患者
3. Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial [J] . Amadori Sergio, Suciu Stefan, Selleslag Dominik, Journal of Clinical Oncology . 2016,第9期

机译：Gemtuzumab Ozogamicin与较新的急性髓样白血病不适合强化化疗的老年患者的最佳支持治疗：III期EORTC-GIMEMA AML-19随机试验的结果
4. Multivariate and subgroup analyses of a randomized multinational phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics [O] . Jiří Mayer, Christopher Arthur, Jacques Delaunay, 2014

机译：对新诊断为急性髓样白血病且细胞遗传学风险中等或中等风险的老年患者进行的地西他滨与治疗选择支持治疗或阿糖胞苷的随机多国3期试验的多变量和亚组分析
5. Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia [O] . Hagop M. Kantarjian, Xavier G. Thomas, Anna Dmoszynska, 2012

机译：多中心，随机，开放标签，阶段审判与患者选择，具有患者建议，用于治疗新诊断的新诊断急性髓性白血病的老年患者

Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics

著录项

引文网络

相似文献

相关主题

期刊订阅